Background: Increased mortality and morbidity are reported in association with high ultrafiltration rate (UFR) and with long dialysis recovery time (DRT). We studied the association between UFR and DRT. Methods: This is a cross-sectional, observational study was conducted. Patients on thrice-weekly hemodialysis (HD) with self-reported DRT between August and December 2014 were included. We examined the association of 30-day average UFR with recovery time. Results: The total number of patients included in this study was 2,689. DRT in categories of immediate recovery, >0-≤2, >2-≤6, >6-≤12, and >12 h, were reported in 27, 28, 17, 9, and 20% of the patients respectively. In multivariable analysis, longer DRT was associated with female gender, non-black race, higher body weight, lower serum albumin, chronic heart failure, cerebrovascular disease, missed dialysis sessions, higher pre-dialysis systolic blood pressure, and larger UF volume. Compared to UFR of <10, UFR ≥13 mL/kg/h was associated with longer DRT, OR of 1.16 (95% CI 0.99-1.36), and 1.28 (95% CI 1.06-1.54) in the unadjusted and the adjusted analyses respectively. Intradialytic hypotension was also associated with longer DRT in the unadjusted (per 10% higher frequency, OR 1.04 [95% CI 1.01-1.07]) and adjusted analyses (OR 1.03 [95% CI 1.00-1.07]). Conclusion: Long recovery time is common after HD. Rapid fluid removal is associated with longer DRT.

Keywords:
Hemodialysis, Ultrafiltration, Minutes to recovery, Recovery time, Quality of life, Fatigue
1.
Horigan AE, Schneider SM, Docherty S, Barroso J: The experience and self-management of fatigue in patients on hemodialysis. Nephrol Nurs J 2013;40:113-122; quiz 123.
2.
Jhamb M, Weisbord SD, Steel JL, Unruh M: Fatigue in patients receiving maintenance dialysis: a review of definitions, measures, and contributing factors. Am J Kidney Dis 2008;52:353-365.
3.
DeOreo PB: Hemodialysis patient-assessed functional health status predicts continued survival, hospitalization, and dialysis-attendance compliance. Am J Kidney Dis 1997;30:204-212.
4.
Kalantar-Zadeh K, Kopple JD, Block G, Humphreys MH: Association among SF36 quality of life measures and nutrition, hospitalization, and mortality in hemodialysis. J Am Soc Nephrol 2001;12:2797-2806.
5.
Lowrie EG, Curtin RB, LePain N, Schatell D: Medical outcomes study short form-36: a consistent and powerful predictor of morbidity and mortality in dialysis patients. Am J Kidney Dis 2003;41:1286-1292.
6.
Nissenson AR: Improving outcomes for ESRD patients: shifting the quality paradigm. Clin J Am Soc Nephrol 2014;9:430-434.
7.
Mehrotra R, Agarwal A, Bargman JM, Himmelfarb J, Johansen KL, Watnick S, Work J, McBryde K, Flessner M, Kimmel PL: Dialysis therapies: a national dialogue. Clin J Am Soc Nephrol 2014;9:812-814.
8.
Newhouse R, Barksdale DJ, Miller JA: The patient-centered outcomes research institute: research done differently. Nurs Res 2015;64:72-77.
9.
Tong A, Chando S, Crowe S, Manns B, Winkelmayer WC, Hemmelgarn B, Craig JC: Research priority setting in kidney disease: a systematic review. Am J Kidney Dis 2015;65:674-683.
10.
Lindsay RM, Heidenheim PA, Nesrallah G, Garg AX, Suri R: Minutes to recovery after a hemodialysis session: a simple health-related quality of life question that is reliable, valid, and sensitive to change. Clin J Am Soc Nephrol 2006;1:952-959.
11.
Rayner HC, Zepel L, Fuller DS, Morgenstern H, Karaboyas A, Culleton BF, Mapes DL, Lopes AA, Gillespie BW, Hasegawa T, Saran R, Tentori F, Hecking M, Pisoni RL, Robinson BM: Recovery time, quality of life, and mortality in hemodialysis patients: the dialysis outcomes and practice patterns study (DOPPS). Am J Kidney Dis 2014;64:86-94.
12.
Flythe JE, Kimmel SE, Brunelli SM: Rapid fluid removal during dialysis is associated with cardiovascular morbidity and mortality. Kidney Int 2011;79:250-257.
13.
Flythe JE, Xue H, Lynch KE, Curhan GC, Brunelli SM: Association of mortality risk with various definitions of intradialytic hypotension. J Am Soc Nephrol 2015;26:724-734.
14.
Stefansson BV, Brunelli SM, Cabrera C, Rosenbaum D, Anum E, Ramakrishnan K, Jensen DE, Stalhammar NO: Intradialytic hypotension and risk of cardiovascular disease. Clin J Am Soc Nephrol 2014;9:2124-2132.
15.
Saran R, Bragg-Gresham JL, Levin NW, Twardowski ZJ, Wizemann V, Saito A, Kimata N, Gillespie BW, Combe C, Bommer J, Akiba T, Mapes DL, Young EW, Port FK: Longer treatment time and slower ultrafiltration in hemodialysis: associations with reduced mortality in the DOPPS. Kidney Int 2006;69:1222-1228.
16.
Movilli E, Gaggia P, Zubani R, Camerini C, Vizzardi V, Parrinello G, Savoldi S, Fischer MS, Londrino F, Cancarini G: Association between high ultrafiltration rates and mortality in uraemic patients on regular haemodialysis. A 5-year prospective observational multicentre study. Nephrol Dial Transplant 2007;22:3547-3552.
17.
Weiner DE, Brunelli SM, Hunt A, Schiller B, Glassock R, Maddux FW, Johnson D, Parker T, Nissenson A: Improving clinical outcomes among hemodialysis patients: A proposal for a “volume first” approach from the chief medical officers of US dialysis providers. Am J Kidney Dis 2014;64:685-695.
18.
Heidenheim AP, Muirhead N, Moist L, Lindsay RM: Patient quality of life on quotidian hemodialysis. Am J Kidney Dis 2003;42(1 suppl):36-41.
19.
Hall YN, Larive B, Painter P, Kaysen GA, Lindsay RM, Nissenson AR, Unruh ML, Rocco MV, Chertow GM: Effects of six versus three times per week hemodialysis on physical performance, health, and functioning: frequent hemodialysis network (FHN) randomized trials. Clin J Am Soc Nephrol 2012;7:782-794.
20.
Weisbord SD, Fried LF, Mor MK, Resnick AL, Unruh ML, Palevsky PM, Levenson DJ, Cooksey SH, Fine MJ, Kimmel PL, Arnold RM: Renal provider recognition of symptoms in patients on maintenance hemodialysis. Clin J Am Soc Nephrol 2007;2:960-967.
21.
Jefferies HJ, Virk B, Schiller B, Moran J, McIntyre CW: Frequent hemodialysis schedules are associated with reduced levels of dialysis-induced cardiac injury (myocardial stunning). Clin J Am Soc Nephrol 2011;6:1326-1332.
22.
Sands JJ, Usvyat LA, Sullivan T, Segal JH, Zabetakis P, Kotanko P, Maddux FW, Diaz-Buxo JA: Intradialytic hypotension: frequency, sources of variation and correlation with clinical outcome. Hemodial Int 2014;18:415-422.
23.
Burton JO, Jefferies HJ, Selby NM, McIntyre CW: Hemodialysis-induced cardiac injury: determinants and associated outcomes. Clin J Am Soc Nephrol 2009;4:914-920.
24.
Schiller B, Arramreddy R, Hussein W: What are the consequences of volume expansion in chronic dialysis patients?: intra-dialytic hypotension in conventional hemodialysis: unavoidable in some, but preventable in most. Semin Dial 2015;28:233-235.
25.
Shoji T, Tsubakihara Y, Fujii M, Imai E: Hemodialysis-associated hypotension as an independent risk factor for two-year mortality in hemodialysis patients. Kidney Int 2004;66:1212-1220.
26.
Lacson E Jr, Xu J, Suri RS, Nesrallah G, Lindsay R, Garg AX, Lester K, Ofsthun N, Lazarus M, Hakim RM: Survival with three-times weekly in-center nocturnal versus conventional hemodialysis. J Am Soc Nephrol 2012;23:687-695.
27.
Hicks LS, Cleary PD, Epstein AM, Ayanian JZ: Differences in health-related quality of life and treatment preferences among black and white patients with end-stage renal disease. Qual Life Res 2004;13:1129-1137.
28.
Weisbord SD, Fried LF, Unruh ML, Kimmel PL, Switzer GE, Fine MJ, Arnold RM: Associations of race with depression and symptoms in patients on maintenance haemodialysis. Nephrol Dial Transplant 2007;22:203-208.
29.
Unruh M, Miskulin D, Yan G, Hays RD, Benz R, Kusek JW, Meyer KB: Racial differences in health-related quality of life among hemodialysis patients. Kidney Int 2004;65:1482-1491.
30.
Kutner NG, Devins GM: A comparison of the quality of life reported by elderly whites and elderly blacks on dialysis. Geriatr Nephrol Urol 1998;8:77-83.
31.
Tell GS, Mittelmark MB, Hylander B, Shumaker SA, Russell G, Burkart JM: Social support and health-related quality of life in black and white dialysis patients. ANNA J 1995;22:301-308; discussion 309-310.
32.
Nemati E, Motalebi M: The gender effect of health-related quality of life in hemodialysis patients. Nephrourol Mon 2014;6:e15934.
33.
von der Lippe N, Waldum B, Osthus TB, Reisaeter AV, Os I: Health related quality of life in patients in dialysis after renal graft loss and effect of gender. BMC Womens Health 2014;14:34.
34.
Lopes GB, Matos CM, Leite EB, Martins MT, Martins MS, Silva LF, Robinson BM, Port FK, James SA, Lopes AA: Depression as a potential explanation for gender differences in health-related quality of life among patients on maintenance hemodialysis. Nephron Clin Pract 2010;115:c35-c40.
35.
Peng YS, Huang JW, Hung KY, Lin BS, Lin CY, Yang CS, Chen TW, Hsia CC, Chen DL, Hsu WD, Chang CF, Wu KD, Lin RP, Tsai TJ, Chen WY: Women on hemodialysis have lower self-reported health-related quality of life scores but better survival than men. J Nephrol 2013;26:366-374.
36.
Honda H, Qureshi AR, Heimburger O, Barany P, Wang K, Pecoits-Filho R, Stenvinkel P, Lindholm B: Serum albumin, C-reactive protein, interleukin 6, and fetuin a as predictors of malnutrition, cardiovascular disease, and mortality in patients with ESRD. Am J Kidney Dis 2006;47:139-148.
37.
Yao Q, Pecoits-Filho R, Lindholm B, Stenvinkel P: Traditional and non-traditional risk factors as contributors to atherosclerotic cardiovascular disease in end-stage renal disease. Scand J Urol Nephrol 2004;38:405-416.
38.
Spiegel BM, Melmed G, Robbins S, Esrailian E: Biomarkers and health-related quality of life in end-stage renal disease: a systematic review. Clin J Am Soc Nephrol 2008;3:1759-1768.
39.
Rambod M, Bross R, Zitterkoph J, Benner D, Pithia J, Colman S, Kovesdy CP, Kopple JD, Kalantar-Zadeh K: Association of malnutrition-inflammation score with quality of life and mortality in hemodialysis patients: a 5-year prospective cohort study. Am J Kidney Dis 2009;53:298-309.
40.
Collins AJ, Ma JZ, Umen A, Keshaviah P: Urea index and other predictors of hemodialysis patient survival. Am J Kidney Dis 1994;23:272-282.
41.
Lowrie EG, Lew NL: Death risk in hemodialysis patients: the predictive value of commonly measured variables and an evaluation of death rate differences between facilities. Am J Kidney Dis 1990;15:458-482.
42.
Owen WF Jr, Lew NL, Liu Y, Lowrie EG, Lazarus JM: The urea reduction ratio and serum albumin concentration as predictors of mortality in patients undergoing hemodialysis. N Engl J Med 1993;329:1001-1006.
43.
Jhamb M, Liang K, Yabes J, Steel JL, Dew MA, Shah N, Unruh M: Prevalence and correlates of fatigue in chronic kidney disease and end-stage renal disease: are sleep disorders a key to understanding fatigue? Am J Nephrol 2013;38:489-495.
44.
Sharp J, Wild MR, Gumley AI, Deighan CJ: A cognitive behavioral group approach to enhance adherence to hemodialysis fluid restrictions: a randomized controlled trial. Am J Kidney Dis 2005;45:1046-1057.
45.
Lindsay RM, Heidenheim AP, Leitch R, Ryan H, Kroeker A, Peters K, Workentin L, Nesrallah G, Prakash S, Kortas C: Short daily versus long nocturnal hemodialysis. Daily/nocturnal dialysis study group. ASAIO J 2001;47:449-455.
46.
Jaber BL, Lee Y, Collins AJ, Hull AR, Kraus MA, McCarthy J, Miller BW, Spry L, Finkelstein FO: Effect of daily hemodialysis on depressive symptoms and postdialysis recovery time: Interim report from the freedom (following rehabilitation, economics and everyday-dialysis outcome measurements) study. Am J Kidney Dis 2010;56:531-539.
© 2017 S. Karger AG, Basel
2017
Copyright / Drug Dosage / Disclaimer
Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.
You do not currently have access to this content.